Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.570
+0.010 (0.63%)
After-hours: Apr 28, 2026, 7:43 PM EDT
Filana Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cost of Revenue | 26.59 | 69.64 | 89.42 | 68.03 | 24.81 | |
| Gross Profit | -26.59 | -69.64 | -89.42 | -68.03 | -24.81 | |
| Selling, General & Admin | 33.5 | 81.71 | 16.63 | 11.99 | 8.06 | |
| Operating Expenses | 33.5 | 81.71 | 16.63 | 11.99 | 8.06 | |
| Operating Income | -60.09 | -151.35 | -106.06 | -80.02 | -32.87 | |
| Interest & Investment Income | 4.62 | 8.51 | 7.83 | 2.78 | 0.05 | |
| Other Non Operating Income (Expenses) | -0.2 | 108.59 | 0.91 | 1 | 0.43 | |
| EBT Excluding Unusual Items | -55.67 | -34.24 | -97.32 | -76.25 | -32.39 | |
| Legal Settlements | -35.3 | - | - | - | - | |
| Pretax Income | -90.97 | -24.34 | -97.22 | -76.25 | -32.39 | |
| Net Income | -90.97 | -24.34 | -97.22 | -76.25 | -32.39 | |
| Net Income to Common | -90.97 | -24.34 | -97.22 | -76.25 | -32.39 | |
| Shares Outstanding (Basic) | 48 | 46 | 42 | 40 | 39 | |
| Shares Outstanding (Diluted) | 48 | 47 | 42 | 40 | 39 | |
| Shares Change (YoY) | 3.63% | 11.14% | 4.30% | 2.02% | 50.95% | |
| EPS (Basic) | -1.88 | -0.53 | -2.32 | -1.90 | -0.82 | |
| EPS (Diluted) | -1.88 | -1.46 | -2.32 | -1.90 | -0.82 | |
| Free Cash Flow | -32.83 | -117.03 | -82.44 | -80.23 | -52.41 | |
| Free Cash Flow Per Share | -0.68 | -2.51 | -1.97 | -2.00 | -1.33 | |
| EBITDA | -59.15 | -150.21 | -104.53 | -78.72 | -32.33 | |
| D&A For EBITDA | 0.94 | 1.13 | 1.53 | 1.3 | 0.53 | |
| EBIT | -60.09 | -151.35 | -106.06 | -80.02 | -32.87 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.